Effects of Microbial Transformation on the Biological Activities of Prenylated Chalcones from Angelica keiskei
- PMID: 35206019
- PMCID: PMC8871312
- DOI: 10.3390/foods11040543
Effects of Microbial Transformation on the Biological Activities of Prenylated Chalcones from Angelica keiskei
Abstract
Microbial transformation is an alternative method for structural modification. The current study aimed at application of microbial transformation for discovering new derivatives and investigating the structure-activity relationship of isobavachalcone (1), 4-hydroxyderricin (2), and xanthoangelol (3) isolated from the herb Angelica keiskei. In the initial screening process, 1-3 were incubated with microbes using a two-stage fermentation method and analyzed through TLC monitoring. The screening results showed that Rhizopus oryzae and Mucor hiemalis were able to transform 1 and 2, respectively. Additionally, M. hiemalis and Mortierella ramanniana var. angulispora were able to transform 3. Following scale-up fermentation, four new (4, 5, 7, and 10) and five known (6, 8, 9, 11, and 12) metabolites were produced. Cytotoxicity of all the compounds (1-12) was investigated using three human cancer cell lines including A375P, HT-29, and MCF-7 by MTT method. Meanwhile, the tyrosinase inhibitory activity of 1-12 was evaluated using l-tyrosine as a substrate. Overall, 1 and 3 displayed the highest cytotoxicity, and 5 and 7 exhibited the most potent tyrosinase inhibitory activity with relatively low cytotoxicity. This allowed us to postulate that the introduction of 4'-O-glucopyranosyl group led to the reduction in cytotoxicity and improvement in tyrosinase inhibitory activity.
Keywords: 4-hydroxyderricin; Angelica keiskei; cytotoxicity; isobavachalcone; microbial transformation; tyrosinase inhibition; xanthoangelol.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Xanthoangelol and 4-Hydroxyderricin Are the Major Active Principles of the Inhibitory Activities against Monoamine Oxidases on Angelica keiskei K.Biomol Ther (Seoul). 2013 May 30;21(3):234-40. doi: 10.4062/biomolther.2012.100. Biomol Ther (Seoul). 2013. PMID: 24265870 Free PMC article.
-
Cytotoxic activities and anti-tumor-promoting effects of microbial transformation products of prenylated chalcones from Angelica keiskei.Chem Biodivers. 2012 Feb;9(2):318-30. doi: 10.1002/cbdv.201100255. Chem Biodivers. 2012. PMID: 22344908
-
Characterizing Tyrosinase Modulators from the Roots of Angelica keiskei Using Tyrosinase Inhibition Assay and UPLC-MS/MS as the Combinatorial Novel Approach.Molecules. 2019 Sep 10;24(18):3297. doi: 10.3390/molecules24183297. Molecules. 2019. PMID: 31510069 Free PMC article.
-
The pharmacology activities of Angelica keiskei Koidzumi and its efficacy and safety in humans.Heliyon. 2024 Jan 13;10(2):e24119. doi: 10.1016/j.heliyon.2024.e24119. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38357325 Free PMC article. Review.
-
Angelica keiskei, an emerging medicinal herb with various bioactive constituents and biological activities.Arch Pharm Res. 2017 Jun;40(6):655-675. doi: 10.1007/s12272-017-0892-3. Epub 2017 Apr 24. Arch Pharm Res. 2017. PMID: 28439780 Free PMC article. Review.
Cited by
-
Finding a Novel Chalcone-Cinnamic Acid Chimeric Compound with Antiproliferative Activity against MCF-7 Cell Line Using a Free-Wilson Type Approach.Molecules. 2023 Jul 18;28(14):5486. doi: 10.3390/molecules28145486. Molecules. 2023. PMID: 37513358 Free PMC article.
-
Polyphenols as Plant-Based Nutraceuticals: Health Effects, Encapsulation, Nano-Delivery, and Application.Foods. 2022 Jul 23;11(15):2189. doi: 10.3390/foods11152189. Foods. 2022. PMID: 35892774 Free PMC article. Review.
-
Advancements in enzymatic reaction-mediated microbial transformation.Heliyon. 2024 Sep 20;10(19):e38187. doi: 10.1016/j.heliyon.2024.e38187. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39430465 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources